Mycosis fungoides causes: Difference between revisions

Jump to navigation Jump to search
Line 18: Line 18:
}}</ref>
}}</ref>


=== Life-threatening Causes[edit | edit source] ===
* Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. There are no life-threatening causes of disease name, however complications resulting from untreated disease name is common.
* Life-threatening causes of [symptom/manifestation] include [cause1], [cause2], and [cause3].
* [Cause] is a life-threatening cause of [disease].
=== Common Causes[edit | edit source] ===
Common causes of [disease name] may include:
* [Cause1]
* [Cause2]
* [Cause3]
OR
* [Disease name] is caused by an infection with [pathogen name].
* [Pathogen name] is caused by [pathogen name].
=== Less Common Causes[edit | edit source] ===
Less common causes of [disease name] include:
* [Cause1]
* [Cause2]
* [Cause3]


==References==
==References==

Revision as of 12:55, 10 December 2018

Cutaneous T cell lymphoma Microchapters

Home

Patient Information

Overview

Classification

Mycosis fungoides
Sezary syndrome

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Sogand Goudarzi, MD [3]

Overview

Development of cutaneous T cell lymphoma is the result of multiple genetic mutations.

Causes

  • The cause of Mycosis fungoides has not been identified.
  • Development of cutaneous T cell lymphoma is the result of multiple genetic mutations.[1][2][3][4][5]


References

  1. Shin, J.; Monti, S.; Aires, D. J.; Duvic, M.; Golub, T.; Jones, D. A.; Kupper, T. S. (2007). "Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome". Blood. 110 (8): 3015–3027. doi:10.1182/blood-2006-12-061507. ISSN 0006-4971.
  2. Wong, Henry K.; Mishra, Anjali; Hake, Timothy; Porcu, Pierluigi (2011). "Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)". British Journal of Haematology. 155 (2): 150–166. doi:10.1111/j.1365-2141.2011.08852.x. ISSN 0007-1048.
  3. Wilcox, Ryan A. (2011). "Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management". American Journal of Hematology. 86 (11): 928–948. doi:10.1002/ajh.22139. ISSN 0361-8609.
  4. Whittaker, Sean (2006). "Biological Insights into the Pathogenesis of Cutaneous T-Cell Lymphomas (CTCL)". Seminars in Oncology. 33: 3–6. doi:10.1053/j.seminoncol.2005.12.015. ISSN 0093-7754.
  5. Henry K. Wong (2013). "Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma". Discovery medicine. 16 (87): 71–78. PMID 23998443. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources